Browsing Bergen Open Research Archive by Author "Sæle, Anna Kristine Myrmel"

Now showing items 1-3 of 3

    • Age-Related Clusters and Favorable Immune Phenotypes in Breast Cancer of the Young Patients 

      Ingebriktsen, Lise Martine; Svanøe, Amalie Abrahamsen; Sæle, Anna Kristine Myrmel; Humlevik, Rasmus Olai Collett; Toska, Karen; Kalvenes, May Britt; Aas, Turid; Heie, Anette; Askeland, Cecilie; Knutsvik, Gøril; Stefansson, Ingunn Marie; Akslen, Lars Andreas; Høivik, Erling André; Wik, Elisabeth (Journal article; Peer reviewed, 2024)
      Breast cancer (BC) patients aged <40 years at diagnosis experience aggressive disease and poorer survival compared with women diagnosed with BC at 40 to 49 years, but the age-related biology is described to little extent. ...

    • Age-related phenotypes in breast cancer: A population-based study 

      Svanøe, Amalie Abrahamsen; Humlevik, Rasmus Olai Collett; Knutsvik, Gøril; Sæle, Anna Kristine Myrmel; Askeland, Cecilie; Ingebriktsen, Lise Martine; Hugaas, Ulrikke; Kvamme, Amalie Bark; Tegnander, Amalie Fagerli; Krüger, Kristi; Davidsen, Benedicte; Høivik, Erling André; Aas, Turid; Stefansson, Ingunn Marie; Akslen, Lars Andreas; Wik, Elisabeth (Journal article; Peer reviewed, 2024)
      Breast cancer in young (<40 years) is associated with a higher frequency of aggressive tumor types and poor prognosis. It remains unclear if there is an underlying age-related biology that contributes to the unfavorable ...

    • A Patient With Maculopapular Rash and Lichenoid Skin Damage Caused by Ponatinib 

      Teigen, Ingrid Anna; Sæle, Anna Kristine Myrmel; Reikvam, Håkon (Journal article; Peer reviewed, 2020)
      Tyrosine kinase inhibitors (TKIs) are invaluable for the treatment of patients with chronic myelogenous leukemia. Although TKIs are generally better tolerated than traditional chemotherapy, dermatologic side effects are ...